Kountouri, A.; Korakas, E.; Ikonomidis, I.; Raptis, A.; Tentolouris, N.; Dimitriadis, G.; Lambadiari, V.
Type 1 Diabetes Mellitus in the SARS-CoV-2 Pandemic: Oxidative Stress as a Major Pathophysiological Mechanism Linked to Adverse Clinical Outcomes. Antioxidants 2021, 10, 752.
https://doi.org/10.3390/antiox10050752
AMA Style
Kountouri A, Korakas E, Ikonomidis I, Raptis A, Tentolouris N, Dimitriadis G, Lambadiari V.
Type 1 Diabetes Mellitus in the SARS-CoV-2 Pandemic: Oxidative Stress as a Major Pathophysiological Mechanism Linked to Adverse Clinical Outcomes. Antioxidants. 2021; 10(5):752.
https://doi.org/10.3390/antiox10050752
Chicago/Turabian Style
Kountouri, Aikaterini, Emmanouil Korakas, Ignatios Ikonomidis, Athanasios Raptis, Nikolaos Tentolouris, George Dimitriadis, and Vaia Lambadiari.
2021. "Type 1 Diabetes Mellitus in the SARS-CoV-2 Pandemic: Oxidative Stress as a Major Pathophysiological Mechanism Linked to Adverse Clinical Outcomes" Antioxidants 10, no. 5: 752.
https://doi.org/10.3390/antiox10050752
APA Style
Kountouri, A., Korakas, E., Ikonomidis, I., Raptis, A., Tentolouris, N., Dimitriadis, G., & Lambadiari, V.
(2021). Type 1 Diabetes Mellitus in the SARS-CoV-2 Pandemic: Oxidative Stress as a Major Pathophysiological Mechanism Linked to Adverse Clinical Outcomes. Antioxidants, 10(5), 752.
https://doi.org/10.3390/antiox10050752
